NCT01769820View on ClinicalTrials.gov

Dexamethasone for Excessive Menstruation

PHASE2CompletedINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 29, 2018

Study Completion Date

April 18, 2018

Conditions

Heavy Menstrual Bleeding

Interventions

DRUG

Dexamethasone

studies 1\&2:0.75mg twice daily for 5 days, starting on day LH (Luteinising Hormone)+8 of menstrual cycle; Study 3 (adaptive) 0.2,0.4,0.5,0.75,0.8,0.9mg twice daily as above

DRUG

placebo

Trial Locations (1)

EH16 4TJ

University of Edinburgh, Edinburgh

All Listed Sponsors

collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER

NCT01769820 - Dexamethasone for Excessive Menstruation | Biotech Hunter | Biotech Hunter